The NeurologyLive® stroke clinical focus page serves as a resource for updates and information related to the clinical care and management of stroke and cerebrovascular disease, featuring news, podcasts, and videos about the latest FDA actions, clinical guideline updates, interviews with physicians, and study and clinical trial findings. The page includes information on stroke, large vessel occlusion, subcranial hemorrhage, intracranial hemorrhage, ischemic stroke, and more.
August 20th 2025
At AHS 2025, Elizabeth Seng, PhD, professor of neurology at Albert Einstein College of Medicine, presented findings from a study showing that migraine was associated with increased odds of ischemic stroke in veterans.
Clopidogrel, Aspirin Combination Lowers Ischemic Event Risk, Slightly Ups Hemorrhage Risk
August 7th 2018In patients with minor ischemic stroke or TIA, the 90-day risk of major ischemic events can be lowered with combination clopidogrel and aspirin compared to only aspirin but slightly raises the risk of major hemorrhage.
Case Study: Vascular Risk Factors Reach Tipping Point
July 24th 2018By the time a 45-year-old patient with hypertension, slurred speech, and weakness in the right arm and right leg was examined in the emergency department, his symptoms had completely disappeared. However, examination, labs, and imaging showed the case was anything but "resolved."
Distinguishing Stroke From Migraine and Stroke Mimics
May 11th 2018While migraine is distinct from stroke in its gradual onset and lack of focal motor weakness, it is also a predisposing factor for childhood stroke. That can raise the question, “Is it another migraine or is it actually stroke this time?”
Oral Contraceptives and Stroke Risk in Women With Migraine
March 22nd 2018Women who have migraines with aura are at increased risk of stroke. Now, a new systematic review suggests that use of combined hormonal contraceptives by these patients raises their stroke risk over and above the already increased risk.
Risk of Intracranial Hemorrhage After tPA: 5 Important Facts
January 17th 2018Intravenous alteplase (tPA) is the standard of care for acute ischemic stroke, if it can be given within 3-4.5 hours after stroke onset. Dr. Wilner reviews some important facts about intracranial hemorrhage after the use of intravenous alterpase.
FDA Approves Riptide Aspiration System for Acute Ischemic Stroke
January 16th 2018The FDA has approved the Riptide Aspiration System for thrombus retrieval via the Arc Catheter for revascularization in patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease.